ViroPharma Inc (VPHM.OQ)
32.45USD
1 Aug 2013
$-1.87 (-5.45%)
$34.32
$32.70
$32.75
$31.40
235,716
221,894
$35.18
$19.59
About
Overall
| Beta: | 1.71 |
| Market Cap (Mil.): | $2,241.48 |
| Shares Outstanding (Mil.): | 65.31 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| VPHM.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.19 | -- | -- |
| ROI: | -7.02 | -2.58 | 18.76 |
| ROE: | -9.93 | -2.66 | 19.59 |
Niche drugmaker ViroPharma attracts takeover interest: sources
NEW YORK - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter.
CORRECTED-UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest - sources
(In June 17 item, corrects in 3rd paragraph to show that ViroPharma is 19 years old)
Niche drugmaker ViroPharma attracts takeover interest: sources
NEW YORK - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter.
UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest -sources
NEW YORK, June 17 - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter.
Orphan drugmaker ViroPharma attracts takeover interest -sources
NEW YORK, June 17 - ViroPharma Inc is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the matter.
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.25 | +0.02 |
| Merck & Co., Inc. (MRK.N) | $48.36 | +0.19 |
| Sanofi SA (SASY.PA) | €76.90 | -3.27 |
| Cubist Pharmaceuticals Inc (CBST.OQ) | $64.05 | +1.72 |
| Acorda Therapeutics Inc (ACOR.OQ) | $37.50 | -0.47 |
| Optimer Pharmaceuticals, Inc. (OPTR.OQ) | $12.62 | +0.11 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ Factual Report
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

